C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/11 (2006.01)
Patent
CA 2720675
A method is provided that includes using an antisense approach to reverse and/or delay an autoimmune diabetes condition in vivo. The oligonucleotides are targeted to bind to primary transcripts CD40, CD80, CD86 and their combinations.
Linvention concerne un procédé comprenant lutilisation dune approche antisens pour inverser et/ou retarder une condition de diabète auto-immun in vivo. Les oligonucléotides sont ciblés pour se lier à des produits de transcription primaires CD40, CD80, CD86 et leurs combinaisons.
Brown Larry R.
Giannoukakis Nick
Trucco Massimo
Baxter Healthcare S.a.
Baxter International Inc.
Sim & Mcburney
University Of Pittsburgh - Of The Commonwealth System Of Higher
LandOfFree
Microsphere-based composition for preventing and/or... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Microsphere-based composition for preventing and/or..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Microsphere-based composition for preventing and/or... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1453641